A new study has shown that energy release may be the molecular mechanism through which our internal clocks control energy balance, findings with implications from dieting to sleep loss.
Sara Becker, PhD, director of IPHAM’s Center for Dissemination and Implementation Science, and C Hendricks Brown, PhD, professor of Psychiatry and of Behavioral Sciences, are principal investigators on a new $15.8 million center grant funded by the National Institute on Drug Abuse.
There is significant variation in the prevalence of obesity among subgroups of Asian American adults, according to a recent Northwestern Medicine study.
Northwestern Medicine investigators continue to investigate the impact of the COVID-19 pandemic, from evaluating repurposed drugs in preventing severe disease to using sentinel surveillance to monitor SARS-CoV-2 transmission rates and studying the prevalence of “long COVID” in pediatric patients.
A new study shows physicians may be choosing to deny care to people with disabilities, and some use discretionary excuses to strategically discharge them from their practice.
Fourth-year medical student Daniel Sasson was a lead author of a study which found that transgender and non-binary adolescents who received top surgery demonstrated improved perceptions of chest dysphoria, gender congruence and body image.
Gen Zers and millennials are approximately two times more likely to be newly diagnosed with high blood pressure during pregnancy, reports a new Northwestern Medicine study.
Northwestern Medicine investigators continue to study COVID-19, from comparing mortality rates between SARS-CoV-2 variants to examining the effectiveness of maternal vaccination in protecting infants and combating COVID-19 misinformation on social media.
Geography played a role in opioid-involved overdose deaths in the past, but a coming wave may discriminate between rural and urban areas, according to a recent study.
Metformin, a common, safe and inexpensive drug for type 2 diabetes, lowered the odds of emergency department visits, hospitalizations or death due to COVID-19 by over 40 percent, according to a new multi-site clinical trial.